J Virol

References in J Virol:

Search this table:

Title	Authors	Year
Purification and characterization of varicella-zoster virus-induced DNA polymerase.	Mar EC, Huang YS, Huang ES	1978
Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS.	Overbaugh J, Rudensey LM, Papenhausen MD, Benveniste RE, Morton WR	1991
Characterization of an Epstein-Barr virus-induced DNA polymerase.	Ooka T, Lenoir G, Daillie J	1979
Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro.	Tsurumi T, Daikoku T, Kurachi R, Nishiyama Y	1993
Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.	Jochmans D, Deval J, Kesteleyn B, Van Marck H, Bettens E, De Baere I, Dehertogh P, Ivens T, Van Ginderen M, Van Schoubroeck B, Ehteshami M, Wigerinck P, Götte M, Hertogs K	2006
Determination of the mutation rate of a retrovirus.	Leider JM, Palese P, Smith FI	1988
Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.	Bestman-Smith J, Boivin G	2003
Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.	Gershburg E, Pagano JS	2002
Identification and some properties of a unique DNA polymerase from cells infected with human B-lymphotropic virus.	Bapat AR, Bodner AJ, Ting RC, Cheng YC	1989
Molecular architecture of adenovirus DNA polymerase and location of the protein primer.	Brenkman AB, Breure EC, van der Vliet PC	2002
Nonstructural proteins of herpes simplex virus. I. Purification of the induced DNA polymerase.	Powell KL, Purifoy DJ	1977
Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1.	Quan Y, Gu Z, Li X, Li Z, Morrow CD, Wainberg MA	1996
Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.	Hall JD, Woodward S	1989
Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.	Lennerstrand J, Hertogs K, Stammers DK, Larder BA	2001
Relationship of Bacillus subtilis DNA polymerase III to bacteriophage PBS2-induced DNA polymerase and to the replication of uracil-containing DNA.	Hitzeman RA, Price AR	1978
Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis.	Hostomsky Z, Hostomska Z, Fu TB, Taylor J	1992
Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity.	Das AT, Vink M, Berkhout B	2005
Adenovirus type 5 DNA binding protein stimulates binding of DNA polymerase to the replication origin.	van Breukelen B, Brenkman AB, Holthuizen PE, van der Vliet PC	2003
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.	Iversen AK, Shafer RW, Wehrly K, Winters MA, Mullins JI, Chesebro B, Merigan TC	1996
Inactivation of bacteriophage T4 by ethyl methanesulfonate: influence of host and viral genotypes.	Ray U, Bartenstein L, Drake JW	1972
Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction.	Hruska JF, Clayton DA, Rubenstein JL, Robinson WS	1977
Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.	Punjabi A, Boyle K, DeMasi J, Grubisha O, Unger B, Khanna M, Traktman P	2001
Mutation to overproduction of bacteriophage T4 gene products.	Karam JD, Bowles MG	1974
Evidence that the nuclease activities associated with the herpes simplex type 1 DNA polymerase are due to the 3'-5' exonuclease.	Hall JD, Orth KL, Claus-Walker D	1996
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase.	Burkham J, Coen DM, Weller SK	1998
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.	Burns DP, Desrosiers RC	1991
Cellular transformation by adenovirus type 5 is influenced by the viral DNA polymerase.	Miller BW, Williams J	1987
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection.	Kerry JA, Priddy MA, Jervey TY, Kohler CP, Staley TL, Vanson CD, Jones TR, Iskenderian AC, Anders DG, Stenberg RM	1996
Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity.	Tenney DJ, Micheletti PA, Stevens JT, Hamatake RK, Matthews JT, Sanchez AR, Hurlburt WW, Bifano M, Cordingley MG	1993
Interaction of a DNA-binding protein, the product of gene D5 of bacteriophage T5, with double-stranded DNA: effects on T5 DNA polymerase functions in vitro.	Fujimura RK, Roop BC	1983
Replication of nondefective parvoviruses: lack of a virion-associated DNA polymerase.	Pritchard C, Patton JT, Bates RC, Stout ER	1978
Translational regulation of herpes simplex virus DNA polymerase.	Yager DR, Marcy AI, Coen DM	1990
Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit.	Tsurumi T, Kobayashi A, Tamai K, Daikoku T, Kurachi R, Nishiyama Y	1993
Structure-function studies of the herpes simplex virus type 1 DNA polymerase.	Haffey ML, Novotny J, Bruccoleri RE, Carroll RD, Stevens JT, Matthews JT	1990
Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity.	Hwang YT, Liu BY, Coen DM, Hwang CB	1997
Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus.	Gerard GF, Grandgenett DP	1975
Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.	Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH	2004
The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1.	Boyer PL, Sarafianos SG, Arnold E, Hughes SH	2002
Suppression of RNA interference by adenovirus virus-associated RNA.	Andersson MG, Haasnoot PC, Xu N, Berenjian S, Berkhout B, Akusjärvi G	2005
Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.	Mulky A, Sarafianos SG, Arnold E, Wu X, Kappes JC	2004
Herpes simplex virus DNA synthesis in a partially purified soluble extract from infected cells.	Pignatti PF, Cassai E, Bertazzoni U	1979
Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase.	Drosopoulos WC, Prasad VR	1996
The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells.	Alvisi G, Roth DM, Camozzi D, Pari GS, Loregian A, Ripalti A, Jans DA	2009
RNase H cleavage of the 5' end of the human immunodeficiency virus type 1 genome.	Gao HQ, Sarafianos SG, Arnold E, Hughes SH	2001
Mutations that decrease DNA binding of the processivity factor of the herpes simplex virus DNA polymerase reduce viral yield, alter the kinetics of viral DNA replication, and decrease the fidelity of DNA replication.	Jiang C, Hwang YT, Randell JC, Coen DM, Hwang CB	2007
Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus.	Burch AD, Weller SK	2005
Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.	Chamberlain PP, Ren J, Nichols CE, Douglas L, Lennerstrand J, Larder BA, Stuart DI, Stammers DK	2002
Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity.	Li JS, Zhou BS, Dutschman GE, Grill SP, Tan RS, Cheng YC	1987
Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.	Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH	2004
Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.	Boyer PL, Sarafianos SG, Arnold E, Hughes SH	2002
Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.	Delviks-Frankenberry KA, Nikolenko GN, Barr R, Pathak VK	2007
Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.	Ooka T, Lenoir GM, Decaussin G, Bornkamm GW, Daillie J	1986
Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.	Tchesnokov EP, Gilbert C, Boivin G, Götte M	2006
Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.	Tian W, Hwang YT, Lu Q, Hwang CB	2009
DNA polymerase requirements for parvovirus H-1 DNA replication in vitro.	Kollek R, Tseng BY, Goulian M	1982
Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks.	Nugent J, Birch-Machin I, Smith KC, Mumford JA, Swann Z, Newton JR, Bowden RJ, Allen GP, Davis-Poynter N	2006
In vivo functional interaction between DNA polymerase and dCMP-hydroxymethylase of bacteriophage T4.	Chao J, Leach M, Karam J	1977
DNA synthesized in the hepatitis B Dane particle DNA polymerase reaction.	Lutwick LI, Robinson WS	1977
The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primase complex.	Marsden HS, McLean GW, Barnard EC, Francis GJ, MacEachran K, Murphy MC, McVey G, Cross A, Abbotts AP, Stow ND	1997
An N-terminal deletion mutant of simian virus 40 (SV40) large T antigen oligomerizes incorrectly on SV40 DNA but retains the ability to bind to DNA polymerase alpha and replicate SV40 DNA in vitro.	Weisshart K, Bradley MK, Weiner BM, Schneider C, Moarefi I, Fanning E, Arthur AK	1996
Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A.	Bonne-Andrea C, Santucci S, Clertant P, Tillier F	1995
Unusual regulation of expression of the herpes simplex virus DNA polymerase gene.	Wobbe KK, Digard P, Staknis D, Coen DM	1993
Two regions of the herpes simplex virus type 1 UL42 protein are required for its functional interaction with the viral DNA polymerase.	Monahan SJ, Barlam TF, Crumpacker CS, Parris DS	1993
Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression.	McDonald WF, Crozel-Goudot V, Traktman P	1992
Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition.	Marcy AI, Hwang CB, Ruffner KL, Coen DM	1990
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.	Hartigan-O'Connor D, Amalfitano A, Chamberlain JS	1999
Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template.	Gottlieb J, Challberg MD	1994
The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication.	Digard P, Bebrin WR, Weisshart K, Coen DM	1993
Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells.	Ertl PF, Powell KL	1992
The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase.	Gallo ML, Dorsky DI, Crumpacker CS, Parris DS	1989
Replication of bacteriophage M13. XIV. Differential inhibition of the replication of M13 and M13 miniphage in a mutant of Escherichia coli defective in the 5' leads to 3' exonuclease associated with DNA polymerase I.	Chen TC, Ray DS	1978
Identification of crucial hydrogen-bonding residues for the interaction of herpes simplex virus DNA polymerase subunits via peptide display, mutational, and calorimetric approaches.	Bridges KG, Chow CS, Coen DM	2001
Effects of exonuclease activity and nucleotide selectivity of the herpes simplex virus DNA polymerase on the fidelity of DNA replication in vivo.	Hwang YT, Liu BY, Hong CY, Shillitoe EJ, Hwang CB	1999
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.	Boyer PL, Sarafianos SG, Arnold E, Hughes SH	2001
Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene.	Lin JC, Sista ND, Besençon F, Kamine J, Pagano JS	1991
Formation of a covalent complex between the terminal protein of pneumococcal bacteriophage Cp-1 and 5'-dAMP.	García P, Hermoso JM, García JA, García E, López R, Salas M	1986
Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.	Taddie JA, Traktman P	1991
Localization of the herpes simplex virus type 1 65-kilodalton DNA-binding protein and DNA polymerase in the presence and absence of viral DNA synthesis.	Goodrich LD, Schaffer PA, Dorsky DI, Crumpacker CS, Parris DS	1990
Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein.	Bush M, Yager DR, Gao M, Weisshart K, Marcy AI, Coen DM, Knipe DM	1991
Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants.	Purifoy DJ, Powell KL	1977
Identification of conserved residues contributing to the activities of adenovirus DNA polymerase.	Liu H, Naismith JH, Hay RT	2000
Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.	Loregian A, Case A, Cancellotti E, Valente C, Marsden HS, Palù G	2006
On the direction of reading of bacteriophage T4 gene 43 (deoxyribonucleic acid polymerase).	O'Donnell PV, Karam JD	1972
Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase.	Acel A, Udashkin BE, Wainberg MA, Faust EA	1998
Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity.	Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH	2003
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.	Hachiya A, Kodama EN, Sarafianos SG, Schuckmann MM, Sakagami Y, Matsuoka M, Takiguchi M, Gatanaga H, Oka S	2008
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.	Lightfoote MM, Coligan JE, Folks TM, Fauci AS, Martin MA, Venkatesan S	1986
Suppression of amber mutations of bacteriophage T4 gene 43 (DNA polymerase) by translational ambiguity.	Karam JD, O'Donnell PV	1973
Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.	Groot F, Geijtenbeek TB, Sanders RW, Baldwin CE, Sanchez-Hernandez M, Floris R, van Kooyk Y, de Jong EC, Berkhout B	2005
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.	van der Hoek L, Back N, Jebbink MF, de Ronde A, Bakker M, Jurriaans S, Reiss P, Parkin N, Berkhout B	2005
Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.	Su HP, Yan Y, Prasad GS, Smith RF, Daniels CL, Abeywickrema PD, Reid JC, Loughran HM, Kornienko M, Sharma S, Grobler JA, Xu B, Sardana V, Allison TJ, Williams PD, Darke PL, Hazuda DJ, Munshi S	2010
Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.	Moss B, Cooper N	1982
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis.	Götte M, Arion D, Parniak MA, Wainberg MA	2000
Evidence against a simple tethering model for enhancement of herpes simplex virus DNA polymerase processivity by accessory protein UL42.	Chaudhuri M, Parris DS	2002
Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.	Knopf KW, Kaufman ER, Crumpacker C	1981
A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.	Hwang YT, Zuccola HJ, Lu Q, Hwang CB	2004
Amino acids 257 to 288 of mouse p48 control the cooperation of polyomavirus large T antigen, replication protein A, and DNA polymerase alpha-primase to synthesize DNA in vitro.	Kautz AR, Weisshart K, Schneider A, Grosse F, Nasheuer HP	2001
Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction.	Berthomme H, Monahan SJ, Parris DS, Jacquemont B, Epstein AL	1995
An ATF/CREB site is the major regulatory element in the human herpesvirus 6 DNA polymerase promoter.	Agulnick AD, Thompson JR, Ricciardi RP	1994
Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding.	Joung I, Engler JA	1992
Expression of herpes simplex virus type 1 DNA polymerase in Saccharomyces cerevisiae and detection of virus-specific enzyme activity in cell-free lysates.	Haffey ML, Stevens JT, Terry BJ, Dorsky DI, Crumpacker CS, Wietstock SM, Ruyechan WT, Field AK	1988
Template requirements for de novo RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase on the viral X RNA.	Kim M, Kim H, Cho SP, Min MK	2002
Human cytomegalovirus-induced DNA polymerase and its interaction with the triphosphates of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil, -5-iodocytosine, and -5-methylcytosine.	Mar EC, Chiou JF, Cheng YC, Huang ES	1985
Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase gene.	Dorsky DI, Crumpacker CS	1990
Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system.	Tsurumi T	1993
Mutator mutations in bacteriophage T4 gene 32 (DNA unwinding protein).	Koch RE, McGaw MK, Drake JW	1976
The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus.	Baltz JL, Filman DJ, Ciustea M, Silverman JE, Lautenschlager CL, Coen DM, Ricciardi RP, Hogle JM	2009
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.	Das AT, Baldwin CE, Vink M, Berkhout B	2005
Processing of lagging-strand intermediates in vitro by herpes simplex virus type 1 DNA polymerase.	Zhu Y, Wu Z, Cardoso MC, Parris DS	2010
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.	Furman PA, Coen DM, St Clair MH, Schaffer PA	1981
Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.	McWilliams MJ, Julias JG, Sarafianos SG, Alvord WG, Arnold E, Hughes SH	2003
Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase.	Gallo ML, Jackwood DH, Murphy MC, Marsden HS, Parris DS	1988
Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine.	Mar EC, Chiou JF, Cheng YC, Huang ES	1985
Distinguishing cytomegalovirus, mycoplasma, and cellular DNA polymerases.	Miller RL, Rapp F	1976
In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.	Matthews JT, Carroll RD, Stevens JT, Haffey ML	1989
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).	Das K, Xiong X, Yang H, Westland CE, Gibbs CS, Sarafianos SG, Arnold E	2001
Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.	Tachedjian G, Mellors J, Bazmi H, Birch C, Mills J	1996
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.	Mansky LM, Temin HM	1995
YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.	Boyer PL, Gao HQ, Clark PK, Sarafianos SG, Arnold E, Hughes SH	2001
Involvement of DNA polymerase alpha in host cell reactivation of UV-irradiated herpes simplex virus.	Nishiyama Y, Yoshida S, Maeno K	1984
Bacteriophage T4 DNA polymerase mutations that confer sensitivity to the PPi analog phosphonoacetic acid.	Reha-Krantz LJ, Nonay RL, Stocki S	1993
In vitro DNA synthesis by an alpha-like DNA polymerase bound to replicating simian virus 40 chromosomes.	Waqar MA, Evans MJ, Burke JF, Tsubota Y, Plummer MJ, Huberman JA	1983
Involvement of Escherichia coli K-12 DNA polymerase I in the growth of bacteriophage Mu.	McBeth DL, Taylor AL	1983
Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.	Verma IM	1975
Reversion of frameshift mutations stimulated by lesions in early function genes of bacteriophage T4.	Bernstein H	1971
Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.	Peletskaya EN, Kogon AA, Tuske S, Arnold E, Hughes SH	2004
Effect of NH4+ ions on phi 29 DNA-protein p3 replication: formation of a complex between the terminal protein and the DNA polymerase.	Blanco L, Prieto I, Gutiérrez J, Bernad A, Lázaro JM, Hermoso JM, Salas M	1987
The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity.	Gottlieb J, Marcy AI, Coen DM, Challberg MD	1990
Specific immune serum to the Epstein-Barr virus DNA polymerase.	Petit RG, Leung K, Shaw JE	1987
Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.	Borkow G, Barnard J, Nguyen TM, Belmonte A, Wainberg MA, Parniak MA	1997
The enhanced DNA replication fidelity of a mutant herpes simplex virus type 1 DNA polymerase is mediated by an improved nucleotide selectivity and reduced mismatch extension ability.	Tian W, Hwang YT, Hwang CB	2008
Locations of amino acid substitutions in bacteriophage T4 tsL56 DNA polymerase predict an N-terminal exonuclease domain.	Reha-Krantz LJ	1989
T4 DNA polymerase (gene 43) is required in vivo for repair of gaps in recombinants.	Miller RC	1975
Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.	Meyer PR, Lennerstrand J, Matsuura SE, Larder BA, Scott WA	2003
Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.	Kallin B, Sternås L, Saemundssen AK, Luka J, Jörnvall H, Eriksson B, Tao PZ, Nilsson MT, Klein G	1985
Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains.	Chan SR, Chandran B	2000
Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity.	Wang YS, Woodward S, Hall JD	1992
Baculovirus induction of a DNA polymerase.	Miller LK, Jewell JE, Browne D	1981
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.	Furman PA, St Clair MH, Fyfe JA, Rideout JL, Keller PM, Elion GB	1979
Bacillus subtilis DNA polymerase III is required for the replication of DNA of bacteriophages SPP-1 and phi 105.	Rowley SD, Brown NC	1977
Host-specific replication of BK virus DNA in mouse cell extracts is independently controlled by DNA polymerase alpha-primase and inhibitory activities.	Tikhanovich I, Nasheuer HP	2010
Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84.	Strang BL, Sinigalia E, Silva LA, Coen DM, Loregian A	2009
Inhibition of the herpes simplex virus type 1 DNA polymerase induces hyperphosphorylation of replication protein A and its accumulation at S-phase-specific sites of DNA damage during infection.	Wilkinson DE, Weller SK	2005
Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus.	Tsurumi T, Daikoku T, Nishiyama Y	1994
Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.	Taddie JA, Traktman P	1993
Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.	Meyer PR, Matsuura SE, Zonarich D, Chopra RR, Pendarvis E, Bazmi HZ, Mellors JW, Scott WA	2003
The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.	Gammon DB, Evans DH	2009
Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44.	Loregian A, Appleton BA, Hogle JM, Coen DM	2004
Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	Loregian A, Rigatti R, Murphy MC, Schievano E, Palù G, Marsden HS	2003
Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.	Gammon DB, Snoeck R, Fiten P, Krecmerová M, Holý A, De Clercq E, Opdenakker G, Evans DH, Andrei G	2008
Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.	Loregian A, Appleton BA, Hogle JM, Coen DM	2004
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.	Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA	1992
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.	Keulen W, Back NK, van Wijk A, Boucher CA, Berkhout B	1997
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.	Harrigan PR, Kinghorn I, Bloor S, Kemp SD, Nájera I, Kohli A, Larder BA	1996

Showing 1 to 154 of 154 entries